Hong Y.K., Lange-Asschenfeldt B., Velasco P., Hirakawa S., Kunstfeld R., Brown L.F., et al. VEGF-A promotes tissue-repair-associated lymphatic vessel formation via VEGFR2 and the α1β1 and α2β1 integrins. FASEB J 18 (2004) 1111-1113
Alitalo K., Tammela T., and Petrova T.V. Lymphangiogenesis in development and human disease. Nature 438 (2005) 946-953
Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5 (2004) 74-80
Jeltsch M., Kaipainen A., Joukov V., Meng X., Lakso M., Rauvala H., et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276 (1997) 1423-1425 Erratum in Science 1997, 277:463
Partanen T.A., Arola J., Saaristo A., Jussila L., Ora A., Miettinen M., et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14 (2000) 2087-2096
Kubo H., Fujiwara T., Jussila L., Hashi H., Ogawa M., Shimizu K., et al. Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96 (2000) 546-553
Saaristo A., Karkkainen M., and Alitalo K. Insights into the molecular pathogenesis and targeted treatment of lymphoedema. Ann N Y Acad Sci 979 (2002) 94-110
Baldwin M., Halford M., Roufail S., Williams R., Hibbs M., Grail D., et al. Vascular endothelial growth factor-D is dispensable for development of the lymphatic system. Mol Cell Biol 25 (2005) 2441-2449
Saharinen P., Tammela T., Karkkainen M., and Alitalo K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25 (2004) 387-395
Banerji S., Ni J., Wang S., Clasper S., Su J., Tammi R., et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144 (1999) 789-801
Rutkowski J.M., Boardman K.C., and Swartz M.A. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am J Physiol Heart Circ Physiol 291 (2006) H1402-H1410
Lazareth I. Classification des lymphœdèmes. Rev Med Interne 23 (2002) 375s-378s
Rockson S. Lymphoedema. Am J Med 110 (2001) 288-295
Karkkainen M., Jussila L., Ferrell R., Finegold D., and Alitalo K. Molecular regulation of lymphangiogenesis and targets for tissue oedema. Trends Mol Med 7 (2001) 18-22
Karkkainen M.J., Saaristo A., Jussila L., Karila K.A., Lawrence E.C., Pajusola K., et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A 98 (2001) 12677-12682
Petrova T.V., Karpanen T., Norrmen C., Mellor R., Tamakoshi T., Finegold D., et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphoedema distichiasis. Nat Med 10 (2004) 974-981
Ruocco V., Schwartz R., and Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol 47 (2002) 124-127
Szuba A., Skobe M., Karkkainen M., Shin W., Beynet D., Rockson N., et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J 16 (2002) 1985-1987
Dadras S.S., Lange-Asschenfeld B., Velasco P., Nguyen L., Vora A., Muzikansky A., et al. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18 (2005) 1232-1242
Maula S.M., Luukkaa M., Grenman R., Jackson D., Jalkanen S., and Ristamaki R. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 63 (2003) 1920-1926
Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20 (2001) 672-682
Straume O., and Akslen L.A. Lymphatic vessel density and prognosis in cutaneous melanoma. Br J Cancer 91 (2004) 1224-1225
Gallo R. The enigma of Kaposi's sarcoma. Science 282 (1998) 1837-1839
Reitz M., Nerurkar L., and Gallo R. Perspective on Kaposi's sarcoma: facts, concepts and conjectures. J Natl Cancer Inst 91 (1999) 1453-1458
Dupin N., and Calvez V. Virus HHV-8/KSHV. I- Aspects épidémiologiques et moléculaires. Ann Dermatol Venereol 127 (2000) 528-531
Wang H., Trotter M., Lagos D., Bourboulia D., Henderson S., Mäkinen T., et al. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet 36 (2004) 687-693
Hong Y., Foreman K., Shin J., Hirakawa S., Curry C., Sage D., et al. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36 (2004) 683-685
Kajiya K., and Detmar M. An important role of lymphatic vessels in the control of UVB-induced edema formation and inflammation. J Invest Dermatol 126 (2006) 919-921
Henno A., Lapière C.M., de la Brassinne M., and Nusgens B. The expression of angiogenesis and lymphangiogenesis markers is higher in normal skin of psoriatic patients than in healthy volunteer skin. J Invest Dermatol 126 (2006) S3-S99 [abstract]